TY - JOUR
T1 - Cannabinoids and glaucoma
AU - Azuara-Blanco, A.
AU - Tomida, I.
AU - Perlwee, R.G.
PY - 2004/5/1
Y1 - 2004/5/1
N2 - Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.
AB - Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.
UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-1942517916&md5=e2f5ebfc24d7649c2d71c93e3df4d783
U2 - 10.1136/bjo.2003.032250
DO - 10.1136/bjo.2003.032250
M3 - Article
AN - SCOPUS:1942517916
SN - 0007-1161
VL - 88
SP - 708
EP - 713
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 5
ER -